US Markets

BUZZ-U.S. STOCKS ON THE MOVE-Organogenesis, Vertex, United Airlines, NantKwest


A compilation of the most active stocks on U.S. exchanges. For faster updates on individual market-movers, Eikon users please use search string "STXBZ US" and Thomson One users please search "RT/STXBZ US".

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter:

The Morning News Call newsletter:

U.S. stock index futures dropped on Thursday as investors braced for weekly jobless claims, which could compound fears of a stalling economic recovery a day after Treasury Secretary Steven Mnuchin dashed hopes for more fiscal aid before the election. .N

At 6:54 a.m. ET, Dow e-minis 1YMc1 were down 0.97% at 28,139. S&P 500 e-minis ESc1 were down 1.01% at 3,446, while Nasdaq 100 e-minis NQc1 were down 1.34% at 11,813.25. The top three NYSE percentage gainers premarket .PRPG.NQ: ** Pennsylvania Real Estate Investment Trust <PEI.N>, up 41.5% ** Superior Industries International Inc <SUP.N>, up 12.2% ** CBL & Associates Properties Inc <CBL.N>, up 10.5% The top three NYSE percentage losers premarket .PRPL.NQ: ** Fastly Inc <FSLY.N>, down 28.3% ** Ranger Energy Services Inc <RNGR.N>, down 9.4% ** Lemonade Inc <LMND.N>, down 8.5% The top three Nasdaq percentage gainers premarket .PRPG.O: ** Staffing 360 Solutions Inc <STAF.O>, up 89.6% ** Organogenesis Holdings Inc <ORGO.O>, up 37.6% ** Huttig Building Products Inc <HBP.O>, up 22.6% The top three Nasdaq percentage losers premarket .PRPL.O: ** Kaixin Auto Holdings <KXIN.O>, down 31.8% ** Vivopower International Plc <VVPR.O>, down 17.8% ** Medalist Diversified Reit Inc <MDRR.O>, down 17.5% ** Vertex VRTX.O: down 9.4% premarket BUZZ- Drops on scrapping trial of deficiency disorder treatment ** United Airlines UAL.O: down 1.3% premarket BUZZ- Dips on bigger-than-expected loss, but cash burn slows ** Organogenesis Holdings ORGO.O: up 37.6% premarket BUZZ- Jumps on forecasting Q3 revenue above Wall Street estimates ** NantKwest NK.O: up 13.1% premarket BUZZ- Up as COVID-19 vaccine development partner gets FDA nod for trial

(Compiled by Dania Nadeem in Bengaluru)


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos


    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at and via Reuters TV.

    Learn More